{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 91, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:19:15Z", "timestamp": 1574475555348}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "Issue 5, Supplement 4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neurology"], "published-print": {"date-parts": [[1998, 11, 1]]}, "DOI": "10.1212/wnl.51.5_suppl_4.s2", "type": "journal-article", "created": {"date-parts": [[2012, 5, 13]], "date-time": "2012-05-13T13:37:02Z", "timestamp": 1336916222000}, "page": "S2-S7", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Pharmacokinetics of antiepileptic drugs"], "prefix": "10.1212", "volume": "51", "author": [{"given": "T. R.", "family": "Browne", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Neurology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T16:54:54Z", "timestamp": 1518195294000}, "score": 34.921326, "issued": {"date-parts": [[1998, 11, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 11, 1]]}, "issue": "Issue 5, Supplement 4"}, "URL": "http://dx.doi.org/10.1212/wnl.51.5_suppl_4.s2", "ISSN": ["0028-3878", "1526-632X"], "issn-type": [{"value": "0028-3878", "type": "print"}, {"value": "1526-632X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T20:40:10Z", "timestamp": 1575405610846}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1978, 9, 1]]}, "DOI": "10.1093/ajhp/35.9.1048", "type": "journal-article", "created": {"date-parts": [[2019, 2, 19]], "date-time": "2019-02-19T21:09:40Z", "timestamp": 1550610580000}, "page": "1048-1056", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Drug Therapy Reviews: Clinical pharmacology of antiepileptic drugs"], "prefix": "10.1093", "volume": "35", "author": [{"given": "Thomas R.", "family": "Browne", "sequence": "first", "affiliation": [{"name": "School of Medicine, Boston University; Chief, Seizure Clinic and Electroencephalography Laboratories, Veterans Administration Hospital, Boston; Clinical Instructor in Neurology, Harvard Medical School; and Assistant in Neurology, Children\u2019s Hospital Medical Center, Boston, Massachusetts."}]}], "member": "286", "container-title": ["American Journal of Health-System Pharmacy"], "language": "en", "link": [{"URL": "http://academic.oup.com/ajhp/article-pdf/35/9/1048/28358288/ajhp1048.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 12]], "date-time": "2019-04-12T22:09:26Z", "timestamp": 1555106966000}, "score": 27.05438, "issued": {"date-parts": [[1978, 9, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1978, 9, 1]]}, "issue": "9"}, "URL": "http://dx.doi.org/10.1093/ajhp/35.9.1048", "ISSN": ["1079-2082", "1535-2900"], "issn-type": [{"value": "1079-2082", "type": "print"}, {"value": "1535-2900", "type": "electronic"}], "subject": ["Health Policy", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T08:41:07Z", "timestamp": 1574239267814}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Neuropharmacology"], "published-print": {"date-parts": [[1988, 4]]}, "DOI": "10.1097/00002826-198804000-00004", "type": "journal-article", "created": {"date-parts": [[2006, 10, 25]], "date-time": "2006-10-25T09:17:31Z", "timestamp": 1161767851000}, "page": "130-140", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Comparative Efficacy of Antiepileptic Drugs"], "prefix": "10.1097", "volume": "11", "author": [{"given": "Mohamad A.", "family": "Mikati", "sequence": "first", "affiliation": []}, {"given": "Thomas R.", "family": "Browne", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Clinical Neuropharmacology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T08:54:35Z", "timestamp": 1518166475000}, "score": 25.276264, "subtitle": [""], "issued": {"date-parts": [[1988, 4]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1097/00002826-198804000-00004", "ISSN": ["0362-5664"], "issn-type": [{"value": "0362-5664", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T18:40:21Z", "timestamp": 1575398421779}, "reference-count": 153, "publisher": "Elsevier", "isbn-type": [{"value": "9780126821031", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1984]]}, "DOI": "10.1016/b978-0-12-682103-1.50011-3", "type": "book-chapter", "created": {"date-parts": [[2013, 11, 19]], "date-time": "2013-11-19T12:41:24Z", "timestamp": 1384864884000}, "page": "139-159", "source": "Crossref", "is-referenced-by-count": 0, "title": ["RECENT DEVELOPMENTS IN THERAPEUTIC DRUG MONITORING OF ANTIEPILEPTIC DRUGS"], "prefix": "10.1016", "author": [{"given": "George K.", "family": "Szabo", "sequence": "first", "affiliation": []}, {"given": "Thomas R.", "family": "Browne", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Trace Analysis"], "deposited": {"date-parts": [[2018, 10, 9]], "date-time": "2018-10-09T17:24:40Z", "timestamp": 1539105880000}, "score": 25.276264, "issued": {"date-parts": [[1984]]}, "ISBN": ["9780126821031"], "references-count": 153, "URL": "http://dx.doi.org/10.1016/b978-0-12-682103-1.50011-3"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:59:52Z", "timestamp": 1574283592879}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Pharmacokinetics"], "published-print": {"date-parts": [[1990, 6]]}, "DOI": "10.2165/00003088-199018060-00001", "type": "journal-article", "created": {"date-parts": [[2009, 3, 4]], "date-time": "2009-03-04T22:22:31Z", "timestamp": 1236205351000}, "page": "423-433", "source": "Crossref", "is-referenced-by-count": 35, "title": ["Stable Isotopes in Clinical Pharmacokinetic Investigations"], "prefix": "10.1007", "volume": "18", "author": [{"given": "Thomas R.", "family": "Browne", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Clinical Pharmacokinetics"], "language": "en", "deposited": {"date-parts": [[2013, 1, 20]], "date-time": "2013-01-20T14:40:28Z", "timestamp": 1358692828000}, "score": 21.236053, "subtitle": ["Advantages and Disadvantages"], "issued": {"date-parts": [[1990, 6]]}, "references-count": 0, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.2165/00003088-199018060-00001", "ISSN": ["0312-5963"], "issn-type": [{"value": "0312-5963", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T11:43:15Z", "timestamp": 1576755795385}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Pharmacokinetics"], "published-print": {"date-parts": [[1998]]}, "DOI": "10.2165/00003088-199835040-00004", "type": "journal-article", "created": {"date-parts": [[2006, 1, 19]], "date-time": "2006-01-19T10:30:03Z", "timestamp": 1137666603000}, "page": "313-329", "source": "Crossref", "is-referenced-by-count": 101, "title": ["Drug Disposition in Cystic Fibrosis"], "prefix": "10.1007", "volume": "35", "author": [{"given": "Elisabeth", "family": "Rey", "sequence": "first", "affiliation": []}, {"given": "Jean-Marc", "family": "Tr??luyer", "sequence": "additional", "affiliation": []}, {"given": "G??rard", "family": "Pons", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Clinical Pharmacokinetics"], "language": "en", "deposited": {"date-parts": [[2013, 1, 20]], "date-time": "2013-01-20T14:36:12Z", "timestamp": 1358692572000}, "score": 19.808624, "subtitle": [""], "issued": {"date-parts": [[1998]]}, "references-count": 0, "journal-issue": {"issue": "4"}, "URL": "http://dx.doi.org/10.2165/00003088-199835040-00004", "ISSN": ["0312-5963"], "issn-type": [{"value": "0312-5963", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:49:10Z", "timestamp": 1574178550713}, "reference-count": 43, "publisher": "Springer Science and Business Media LLC", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs & Aging"], "published-print": {"date-parts": [[2001]]}, "DOI": "10.2165/00002512-200118100-00002", "type": "journal-article", "created": {"date-parts": [[2006, 1, 21]], "date-time": "2006-01-21T00:19:16Z", "timestamp": 1137802756000}, "page": "725-735", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Current Management Strategies for Hepatitis B in the Elderly"], "prefix": "10.1007", "volume": "18", "author": [{"given": "Philippe", "family": "Merle", "sequence": "first", "affiliation": []}, {"given": "Christian", "family": "Tr??po", "sequence": "additional", "affiliation": []}, {"given": "Fabien", "family": "Zoulim", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "R1-2", "author": "Lee", "volume": "337", "first-page": "1733", "year": "1997", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199712113372406", "doi-asserted-by": "crossref"}, {"key": "R2-2", "author": "Hoofnagle", "volume": "336", "first-page": "347", "year": "1997", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199701303360507", "doi-asserted-by": "crossref"}, {"key": "R3-2", "author": "Gunther", "volume": "52", "first-page": "25", "year": "1999", "journal-title": "Adv Virus Res", "DOI": "10.1016/S0065-3527(08)60298-5", "doi-asserted-by": "crossref"}, {"key": "R4-2", "author": "Grandjacques", "volume": "33", "first-page": "430", "year": "2000", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(00)80279-2", "doi-asserted-by": "crossref"}, {"key": "R5-2", "author": "Stuyver", "volume": "81", "first-page": "67", "year": "2000", "journal-title": "J Gen Virol", "DOI": "10.1099/0022-1317-81-1-67", "doi-asserted-by": "crossref"}, {"key": "R6-2", "author": "Chisari", "volume": "22", "first-page": "1316", "year": "1995", "journal-title": "Hepatology"}, {"key": "R7-2", "author": "Trepo", "volume": "11", "first-page": "S95", "year": "1990", "journal-title": "J Hepatol", "DOI": "10.1016/0168-8278(90)90172-N", "doi-asserted-by": "crossref"}, {"key": "R8-2", "author": "Marcus", "volume": "45", "first-page": "755", "year": "1997", "journal-title": "J Am Geriatr Soc", "DOI": "10.1111/j.1532-5415.1997.tb01484.x", "doi-asserted-by": "crossref"}, {"key": "R10-2", "author": "Chu", "volume": "3", "first-page": "431", "year": "1985", "journal-title": "Hepatology", "DOI": "10.1002/hep.1840050315", "doi-asserted-by": "crossref"}, {"key": "R11-2", "author": "Hoofnagle", "volume": "7", "first-page": "758", "year": "1987", "journal-title": "Hepatology", "DOI": "10.1002/hep.1840070424", "doi-asserted-by": "crossref"}, {"key": "R12-2", "author": "Lindh", "volume": "4", "first-page": "258", "year": "2000", "journal-title": "J Viral Hepat", "DOI": "10.1046/j.1365-2893.2000.00236.x", "doi-asserted-by": "crossref"}, {"key": "R13-2", "author": "Pichoud", "volume": "32", "first-page": "307", "year": "2000", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(00)80077-X", "doi-asserted-by": "crossref"}, {"key": "R14-2", "author": "Liaw", "volume": "30", "first-page": "579", "year": "1999", "journal-title": "Hepatology", "DOI": "10.1002/hep.510300221", "doi-asserted-by": "crossref"}, {"key": "R15-2", "author": "Brechot", "volume": "I", "first-page": "765", "year": "1981", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(81)90182-3", "doi-asserted-by": "crossref"}, {"key": "R16-2", "author": "Li", "volume": "71", "first-page": "1993", "year": "1990", "journal-title": "J Gen Virol", "DOI": "10.1099/0022-1317-71-9-1993", "doi-asserted-by": "crossref"}, {"key": "R17-2", "author": "Sherman", "volume": "22", "first-page": "432", "year": "1995", "journal-title": "Hepatology"}, {"key": "R18-2", "author": "Zoulim", "volume": "44", "first-page": "1", "year": "1999", "journal-title": "Antiviral Res", "DOI": "10.1016/S0166-3542(99)00056-X", "doi-asserted-by": "crossref"}, {"key": "R19-2", "author": "Tine", "volume": "18", "first-page": "154", "year": "1993", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(05)80241-7", "doi-asserted-by": "crossref"}, {"key": "R20-2", "author": "Lok", "volume": "105", "first-page": "1833", "year": "1993", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(93)91082-S", "doi-asserted-by": "crossref"}, {"key": "R21-2", "author": "Perrillo", "volume": "115", "first-page": "113", "year": "1991", "journal-title": "Ann Med Int", "DOI": "10.7326/0003-4819-115-2-113", "doi-asserted-by": "crossref"}, {"key": "R22-2", "author": "Korenman", "volume": "114", "first-page": "629", "year": "1991", "journal-title": "Ann Intern Med", "DOI": "10.7326/0003-4819-114-8-629", "doi-asserted-by": "crossref"}, {"key": "R23-2", "author": "Lin", "volume": "29", "first-page": "971", "year": "1999", "journal-title": "Hepatology", "DOI": "10.1002/hep.510290312", "doi-asserted-by": "crossref"}, {"key": "R24-2", "author": "Niederau", "volume": "334", "first-page": "1422", "year": "1996", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199605303342202", "doi-asserted-by": "crossref"}, {"key": "R25-2", "author": "Carreno", "volume": "15", "first-page": "102", "year": "1992", "journal-title": "J Hepatol", "DOI": "10.1016/0168-8278(92)90019-L", "doi-asserted-by": "crossref"}, {"key": "R26-2", "author": "Perrillo", "volume": "38", "first-page": "577", "year": "1993", "journal-title": "Dig Dis Sci", "DOI": "10.1007/BF01316785", "doi-asserted-by": "crossref"}, {"key": "R27-2", "author": "Brunetto", "volume": "105", "first-page": "845", "year": "1993", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(93)90903-P", "doi-asserted-by": "crossref"}, {"key": "R28-2", "author": "Lampertico", "volume": "26", "first-page": "1621", "year": "1997", "journal-title": "Hepatology", "DOI": "10.1002/hep.510260634", "doi-asserted-by": "crossref"}, {"key": "R29-2", "author": "Zhang", "volume": "48", "first-page": "8", "year": "1996", "journal-title": "J Med Virol", "DOI": "10.1002/(SICI)1096-9071(199601)48:1<8::AID-JMV2>3.0.CO;2-E", "doi-asserted-by": "crossref"}, {"key": "R31-2", "author": "Perrillo", "volume": "109", "first-page": "908", "year": "1995", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(95)90401-8", "doi-asserted-by": "crossref"}, {"key": "R32-2", "author": "Schalm", "volume": "46", "first-page": "562", "year": "2000", "journal-title": "Gut", "DOI": "10.1136/gut.46.4.562", "doi-asserted-by": "crossref"}, {"key": "R36-2", "author": "Lai", "volume": "339", "first-page": "61", "year": "1998", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199807093390201", "doi-asserted-by": "crossref"}, {"key": "R37-2", "author": "Dienstag", "volume": "341", "first-page": "1256", "year": "1999", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199910213411702", "doi-asserted-by": "crossref"}, {"key": "R38-2", "author": "Si Ahmed", "volume": "32", "first-page": "1078", "year": "2000", "journal-title": "Hepatology", "DOI": "10.1053/jhep.2000.19619", "doi-asserted-by": "crossref"}, {"key": "R39-2", "author": "Torresi", "volume": "118", "first-page": "S83", "year": "2000", "journal-title": "Gastroenterology", "DOI": "10.1016/S0016-5085(00)70008-4", "doi-asserted-by": "crossref"}, {"key": "R40-2", "author": "Nowak", "volume": "93", "first-page": "4398", "year": "1996", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.93.9.4398", "doi-asserted-by": "crossref"}, {"key": "R41-2", "author": "Song", "volume": "32", "first-page": "803", "year": "2000", "journal-title": "Hepatology", "DOI": "10.1053/jhep.2000.16665", "doi-asserted-by": "crossref"}, {"key": "R42-2", "author": "Allen", "volume": "27", "first-page": "1670", "year": "1998", "journal-title": "Hepatology", "DOI": "10.1002/hep.510270628", "doi-asserted-by": "crossref"}, {"key": "R43-2", "author": "Liaw", "volume": "119", "first-page": "172", "year": "2000", "journal-title": "Gastroenterology", "DOI": "10.1053/gast.2000.8559", "doi-asserted-by": "crossref"}, {"key": "R44-2", "author": "Hadziyannis", "volume": "32", "first-page": "847", "year": "2000", "journal-title": "Hepatology", "DOI": "10.1053/jhep.2000.17915", "doi-asserted-by": "crossref"}, {"key": "R45-2", "author": "Honkoop", "volume": "32", "first-page": "635", "year": "2000", "journal-title": "Hepatology", "DOI": "10.1053/jhep.2000.16333", "doi-asserted-by": "crossref"}, {"key": "R46-2", "author": "Shibata", "volume": "13", "first-page": "5451", "year": "1997", "journal-title": "Clin Ther Med"}, {"key": "R47-2", "author": "Tassopoulos", "volume": "29", "first-page": "889", "year": "1999", "journal-title": "Hepatology", "DOI": "10.1002/hep.510290321", "doi-asserted-by": "crossref"}, {"key": "R48-2", "author": "Villeneuve", "volume": "31", "first-page": "207", "year": "2000", "journal-title": "Hepatology", "DOI": "10.1002/hep.510310130", "doi-asserted-by": "crossref"}], "container-title": ["Drugs & Aging"], "language": "en", "deposited": {"date-parts": [[2019, 3, 21]], "date-time": "2019-03-21T14:31:45Z", "timestamp": 1553178705000}, "score": 19.402985, "subtitle": [""], "issued": {"date-parts": [[2001]]}, "references-count": 43, "journal-issue": {"issue": "10"}, "URL": "http://dx.doi.org/10.2165/00002512-200118100-00002", "relation": {"cites": []}, "ISSN": ["1170-229X"], "issn-type": [{"value": "1170-229X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:44:22Z", "timestamp": 1574178262749}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Pharmacokinetics"], "published-print": {"date-parts": [[1999]]}, "DOI": "10.2165/00003088-199936060-00003", "type": "journal-article", "created": {"date-parts": [[2006, 1, 19]], "date-time": "2006-01-19T10:30:26Z", "timestamp": 1137666626000}, "page": "409-424", "source": "Crossref", "is-referenced-by-count": 66, "title": ["Pharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures"], "prefix": "10.1007", "volume": "36", "author": [{"given": "Elisabeth", "family": "Rey", "sequence": "first", "affiliation": []}, {"given": "Jean-Marc", "family": "Tr??luyer", "sequence": "additional", "affiliation": []}, {"given": "G??rard", "family": "Pons", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Clinical Pharmacokinetics"], "language": "en", "deposited": {"date-parts": [[2013, 1, 20]], "date-time": "2013-01-20T14:24:21Z", "timestamp": 1358691861000}, "score": 18.722092, "subtitle": ["Focus on Delivery Routes"], "issued": {"date-parts": [[1999]]}, "references-count": 0, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.2165/00003088-199936060-00003", "ISSN": ["0312-5963"], "issn-type": [{"value": "0312-5963", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T14:04:15Z", "timestamp": 1574690655187}, "reference-count": 0, "publisher": "GN1 Genesis Network", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1964]]}, "DOI": "10.5935/0305-7518.19640034", "type": "journal-article", "created": {"date-parts": [[2015, 5, 4]], "date-time": "2015-05-04T12:48:02Z", "timestamp": 1430743682000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Polysensitivity to Anti-Leprosy Drugs"], "prefix": "10.5935", "volume": "35", "author": [{"given": "S. G.", "family": "BROWNE", "sequence": "first", "affiliation": []}], "member": "3948", "container-title": ["Leprosy Review"], "language": "en", "link": [{"URL": "http://leprev.ilsl.br/pdfs/1964/v35n4/pdf/v35n4a05.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 26]], "date-time": "2016-12-26T17:56:35Z", "timestamp": 1482774995000}, "score": 18.288548, "issued": {"date-parts": [[1964]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1964]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.5935/0305-7518.19640034", "ISSN": ["0305-7518"], "issn-type": [{"value": "0305-7518", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T13:59:32Z", "timestamp": 1574776772480}, "reference-count": 24, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/4.0", "start": {"date-parts": [[2016, 3, 17]], "date-time": "2016-03-17T00:00:00Z", "timestamp": 1458172800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Drugs R D"], "published-print": {"date-parts": [[2016, 6]]}, "DOI": "10.1007/s40268-016-0127-y", "type": "journal-article", "created": {"date-parts": [[2016, 3, 18]], "date-time": "2016-03-18T19:56:22Z", "timestamp": 1458330982000}, "page": "181-191", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers"], "prefix": "10.1007", "volume": "16", "author": [{"given": "Stephen", "family": "Pawsey", "sequence": "first", "affiliation": []}, {"given": "Mike", "family": "Wood", "sequence": "additional", "affiliation": []}, {"given": "Helen", "family": "Browne", "sequence": "additional", "affiliation": []}, {"given": "Kirsteen", "family": "Donaldson", "sequence": "additional", "affiliation": []}, {"given": "Mark", "family": "Christie", "sequence": "additional", "affiliation": []}, {"given": "Steven", "family": "Warrington", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 3, 17]]}, "reference": [{"key": "127_CR1", "doi-asserted-by": "crossref", "first-page": "S163", "DOI": "10.1038/sj.bjp.0706406", "volume": "147", "author": "RG Pertwee", "year": "2006", "unstructured": "Pertwee RG. Cannabinoid pharmacology: the first 66\u00a0years. Br J Pharmacol. 2006;147:S163\u201371.", "journal-title": "Br J Pharmacol."}, {"key": "127_CR2", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1054/plef.2001.0340", "volume": "66", "author": "R Mechoulam", "year": "2002", "unstructured": "Mechoulam R. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression. Prostaglandins Leukot Essent Fatty Acids. 2002;66:93\u20139.", "journal-title": "Prostaglandins Leukot Essent Fatty Acids."}, {"key": "127_CR3", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1093/bja/aen107", "volume": "101", "author": "A Dray", "year": "2008", "unstructured": "Dray A. Neuropathic pain: emerging treatments. Br J Anaesth. 2008;101:48\u201358.", "journal-title": "Br J Anaesth."}, {"key": "127_CR4", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1159/000057150", "volume": "6", "author": "RG Pertwee", "year": "1999", "unstructured": "Pertwee RG. Cannabis and cannabinoids: pharmacology and rationale for clinical use. Forsch Komplementarmed. 1999;6:12\u20135.", "journal-title": "Forsch Komplementarmed."}, {"key": "127_CR5", "first-page": "859", "volume": "3", "author": "PF Smith", "year": "2002", "unstructured": "Smith PF. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis. Curr Opin Investig Drugs. 2002;3:859\u201364.", "journal-title": "Curr Opin Investig Drugs."}, {"key": "127_CR6", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1136/bmj.323.7303.13", "volume": "323", "author": "FA Campbell", "year": "2001", "unstructured": "Campbell FA, Tram\u00e8r MR, Carroll D, et al. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ. 2001;323:13\u20136.", "journal-title": "BMJ."}, {"key": "127_CR7", "doi-asserted-by": "crossref", "first-page": "2238", "DOI": "10.1073/pnas.94.6.2238", "volume": "94", "author": "DK Giang", "year": "1997", "unstructured": "Giang DK, Cravatt BF. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci USA. 1997;94:2238\u201342.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "127_CR8", "doi-asserted-by": "crossref", "first-page": "36569", "DOI": "10.1074/jbc.M606646200", "volume": "281", "author": "BQ Wei", "year": "2006", "unstructured": "Wei BQ, Mikkelsen TS, McKinney MK, et al. A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem. 2006;281:36569\u201378.", "journal-title": "J Biol Chem."}, {"key": "127_CR9", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1016/j.pain.2004.01.022", "volume": "109", "author": "AH Lichtman", "year": "2004", "unstructured": "Lichtman AH, Shelton CC, Advani T, Cravatt BF. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor mediated phenotypic hypoalgesia. Pain. 2004;109:319\u201327.", "journal-title": "Pain."}, {"key": "127_CR10", "doi-asserted-by": "crossref", "first-page": "1202", "DOI": "10.1172/JCI200419465", "volume": "113", "author": "F Massa", "year": "2004", "unstructured": "Massa F, Marsicano G, Hermann H, et al. The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest. 2004;113:1202\u20139.", "journal-title": "J Clin Invest."}, {"key": "127_CR11", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1038/sj.bjp.0706348", "volume": "146", "author": "S Holt", "year": "2005", "unstructured": "Holt S, Comelli F, Costa B, Fowler CJ. Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors. Br J Pharmacol. 2005;146:467\u201376.", "journal-title": "Br J Pharmacol."}, {"key": "127_CR12", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1038/sj.bjp.0706699", "volume": "148", "author": "L Chang", "year": "2006", "unstructured": "Chang L, Luo L, Palmer JA, et al. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. Br J Pharmacol. 2006;148:102\u201313.", "journal-title": "Br J Pharmacol."}, {"key": "127_CR13", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1016/S1367-5931(03)00079-6", "volume": "7", "author": "BF Cravatt", "year": "2003", "unstructured": "Cravatt BF, Lichtman AH. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol. 2003;7:469\u201375.", "journal-title": "Curr Opin Chem Biol."}, {"key": "127_CR14", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1517/17460441.2013.780021", "volume": "8", "author": "T Bisogno", "year": "2013", "unstructured": "Bisogno T, Maccarrone M. Latest advances in the discovery of fatty acid amide hydrolase inhibitors. Expert Opin Drug Discov. 2013;8:509\u201322.", "journal-title": "Expert Opin Drug Discov."}, {"key": "127_CR15", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1021/ml100190t", "volume": "2", "author": "DS Johnson", "year": "2011", "unstructured": "Johnson DS, Stiff C, Lazerwith SE, et al. Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor. ACS Med Chem Lett. 2011;2:91\u20136.", "journal-title": "ACS Med Chem Lett."}, {"key": "127_CR16", "doi-asserted-by": "crossref", "first-page": "706", "DOI": "10.1111/j.1365-2125.2011.04137.x", "volume": "73", "author": "GL Li", "year": "2012", "unstructured": "Li GL, Winter H, Arends R, et al. Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects. Br J Clin Pharmacol. 2012;73:706\u201316.", "journal-title": "Br J Clin Pharmacol."}, {"key": "127_CR17", "doi-asserted-by": "crossref", "first-page": "1837", "DOI": "10.1016/j.pain.2012.04.020", "volume": "153", "author": "JP Huggins", "year": "2012", "unstructured": "Huggins JP, Smart TS, Langman S, et al. An efficient randomized, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee. Pain. 2012;153:1837\u201346.", "journal-title": "Pain."}, {"key": "127_CR18", "doi-asserted-by": "crossref", "first-page": "1785", "DOI": "10.1016/j.pain.2012.06.016", "volume": "153", "author": "V Marzo Di", "year": "2012", "unstructured": "Di Marzo V. Inhibitors of endocannabinoid breakdown for pain: not so FA(AH)cile, after all. Pain. 2012;153:1785\u20136.", "journal-title": "Pain."}, {"key": "127_CR19", "doi-asserted-by": "crossref", "first-page": "959", "DOI": "10.1016/j.pain.2011.02.034", "volume": "152", "author": "AH Lichtman", "year": "2011", "unstructured": "Lichtman AH, Chapman V. A FAAH-fetched approach to treat osteoarthritis pain. Pain. 2011;152:959\u201360.", "journal-title": "Pain."}, {"key": "127_CR20", "unstructured": "Roughley, S, Walls, S, Hart, T, et al. Azetidine derivatives. International patent WO2009/109743."}, {"key": "127_CR21", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1016/j.chembiol.2009.02.013", "volume": "16", "author": "K Ahn", "year": "2009", "unstructured": "Ahn K, Johnson DS, Mileni M, et al. Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol. 2009;16:411\u201320.", "journal-title": "Chem Biol."}, {"key": "127_CR22", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1016/j.bcp.2009.04.024", "volume": "78", "author": "HS Hansen", "year": "2009", "unstructured": "Hansen HS, Diep TA. N-acylethanolamines, anandamide and food intake. Biochem Pharmacol. 2009;78:553\u201360.", "journal-title": "Biochem Pharmacol."}, {"key": "127_CR23", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1007/BF02243994", "volume": "100", "author": "DB Campbell", "year": "1990", "unstructured": "Campbell DB. The use of kinetic-dynamic interactions in the evaluation of drugs. Psychopharmacology (Berl). 1990;100:433\u201350.", "journal-title": "Psychopharmacology (Berl)."}, {"key": "127_CR24", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/S0009-3084(00)00190-0", "volume": "108", "author": "N Ueda", "year": "2000", "unstructured": "Ueda N, Puffenbarger RA, Yamamoto S, Deutsch DG. The fatty acid amide hydrolase (FAAH). Chem Phys Lipids. 2000;108:107\u201321.", "journal-title": "Chem Phys Lipids."}], "container-title": ["Drugs in R&D"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s40268-016-0127-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s40268-016-0127-y/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s40268-016-0127-y", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 26]], "date-time": "2019-03-26T19:15:30Z", "timestamp": 1553627730000}, "score": 17.856972, "issued": {"date-parts": [[2016, 3, 17]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2016, 6]]}, "issue": "2"}, "alternative-id": ["127"], "URL": "http://dx.doi.org/10.1007/s40268-016-0127-y", "relation": {"cites": []}, "ISSN": ["1174-5886", "1179-6901"], "issn-type": [{"value": "1174-5886", "type": "print"}, {"value": "1179-6901", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T23:39:32Z", "timestamp": 1574465972661}, "reference-count": 0, "publisher": "InTech", "isbn-type": [{"value": "9789535102373", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5772/30377", "type": "book-chapter", "created": {"date-parts": [[2012, 4, 3]], "date-time": "2012-04-03T13:21:58Z", "timestamp": 1333459318000}, "source": "Crossref", "is-referenced-by-count": 1, "title": ["Drugs in Development for Opioid-Induced Constipation"], "prefix": "10.5772", "author": [{"given": "Kelly", "family": "S.", "sequence": "first", "affiliation": []}, {"given": "Egilius", "family": "L.H.", "sequence": "additional", "affiliation": []}, {"given": "Dustin", "family": "Tr", "sequence": "additional", "affiliation": []}], "member": "3774", "published-online": {"date-parts": [[2012, 3, 7]]}, "container-title": ["Constipation - Causes, Diagnosis and Treatment"], "link": [{"URL": "http://www.intechopen.com/download/pdf/31222", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 29]], "date-time": "2016-12-29T11:08:56Z", "timestamp": 1483009736000}, "score": 17.845566, "issued": {"date-parts": [[2012, 3, 7]]}, "ISBN": ["9789535102373"], "references-count": 0, "URL": "http://dx.doi.org/10.5772/30377"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:14:10Z", "timestamp": 1574295250389}, "reference-count": 0, "publisher": "BMJ", "issue": "5786", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["BMJ"], "published-print": {"date-parts": [[1971, 11, 27]]}, "DOI": "10.1136/bmj.4.5786.558-b", "type": "journal-article", "created": {"date-parts": [[2009, 4, 8]], "date-time": "2009-04-08T19:21:07Z", "timestamp": 1239218467000}, "page": "558-559", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Antileprosy drugs."], "prefix": "10.1136", "volume": "4", "author": [{"given": "S G", "family": "Browne", "sequence": "first", "affiliation": []}], "member": "239", "container-title": ["BMJ"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/bmj.4.5786.558-b", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 24]], "date-time": "2016-12-24T05:49:19Z", "timestamp": 1482558559000}, "score": 17.726032, "issued": {"date-parts": [[1971, 11, 27]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1971, 11, 27]]}, "issue": "5786"}, "URL": "http://dx.doi.org/10.1136/bmj.4.5786.558-b", "ISSN": ["0959-8138", "1468-5833"], "issn-type": [{"value": "0959-8138", "type": "print"}, {"value": "1468-5833", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:50:55Z", "timestamp": 1574491855081}, "reference-count": 7, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 12053, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["British Journal of Clinical Pharmacology"], "published-print": {"date-parts": [[1982, 9]]}, "DOI": "10.1111/j.1365-2125.1982.tb02008.x", "type": "journal-article", "created": {"date-parts": [[2012, 7, 26]], "date-time": "2012-07-26T16:58:23Z", "timestamp": 1343321903000}, "page": "453-455", "source": "Crossref", "is-referenced-by-count": 23, "title": ["The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole."], "prefix": "10.1111", "volume": "14", "author": [{"given": "M", "family": "Dawson", "sequence": "first", "affiliation": []}, {"given": "RJ", "family": "Allan", "sequence": "additional", "affiliation": []}, {"given": "TR", "family": "Watson", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 7, 26]]}, "reference": [{"key": "10.1111/j.1365-2125.1982.tb02008.x-BIB2685|cit2", "first-page": "633", "article-title": "Medical treatment for hydatids.", "volume": "1", "author": "BEARD", "year": "1978", "journal-title": "Med. J. Aust."}, {"key": "10.1111/j.1365-2125.1982.tb02008.x-BIB2686|cit3", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1136/bmj.2.6094.1047", "article-title": "Treatment of hepatic hydatid disease with mebendazole. Preliminary results in four cases.", "volume": "2", "author": "BEKHTI", "year": "1977", "journal-title": "Br. med. J."}, {"key": "10.1111/j.1365-2125.1982.tb02008.x-BIB2687|cit4", "author": "BRAITHWAITE", "year": "1982", "article-title": "Clinical pharmacokinetics of high dose mebendazole in patients treated for Cystic hydatid disease.", "journal-title": "Eur. J. clin. Pharmacokin.", "DOI": "10.1007/BF00542462", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1365-2125.1982.tb02008.x-BIB2688|cit5", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1001/jama.1971.03190030039008", "article-title": "Mebendazole in enterobiasis. Radiochemical and pilot study in 1, 278 subjects.", "volume": "217", "author": "BRUGMANS", "year": "1971", "journal-title": "J. Am. med. Ass."}, {"key": "10.1111/j.1365-2125.1982.tb02008.x-BIB2689|cit6", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1007/BF00558451", "article-title": "Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results.", "volume": "17", "author": "M\u00dcNST", "year": "1980", "journal-title": "Eur. J. clin. Pharmac."}, {"key": "10.1111/j.1365-2125.1982.tb02008.x-BIB2690|cit7", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1016/S0140-6736(81)90880-1", "article-title": "Chemotherapy of onchoceriasis: a controlled comparison of mebendazole, levamisole and diethylcarbamazine.", "volume": "ii", "author": "RIVAS-ALCAL\u00c5", "year": "1981", "journal-title": "Lancet"}, {"key": "10.1111/j.1365-2125.1982.tb02008.x-BIB2691|cit8", "author": "WITASSEK", "year": "1980", "volume-title": "Union of Swiss Societies of Experimental Biology, 12th Annual Meeting."}], "container-title": ["British Journal of Clinical Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1982.tb02008.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T22:01:17Z", "timestamp": 1497996077000}, "score": 17.435425, "issued": {"date-parts": [[1982, 9]]}, "references-count": 7, "journal-issue": {"published-print": {"date-parts": [[1982, 9]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1111/j.1365-2125.1982.tb02008.x", "relation": {"cites": []}, "ISSN": ["0306-5251"], "issn-type": [{"value": "0306-5251", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:23:09Z", "timestamp": 1574130189000}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Transactions of the Royal Society of Tropical Medicine and Hygiene"], "published-print": {"date-parts": [[1967, 1]]}, "DOI": "10.1016/0035-9203(67)90113-7", "type": "journal-article", "created": {"date-parts": [[2004, 6, 21]], "date-time": "2004-06-21T12:43:57Z", "timestamp": 1087821837000}, "page": "601-607", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The clinical evaluation of drugs for leprosy"], "prefix": "10.1093", "volume": "61", "author": [{"given": "S.G.", "family": "Browne", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["Transactions of the Royal Society of Tropical Medicine and Hygiene"], "language": "en", "link": [{"URL": "http://academic.oup.com/trstmh/article-pdf/61/4/601/5451072/61-4-601.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T06:40:35Z", "timestamp": 1503556835000}, "score": 17.172869, "issued": {"date-parts": [[1967, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1967, 1]]}, "issue": "4"}, "alternative-id": ["0035920367901137"], "URL": "http://dx.doi.org/10.1016/0035-9203(67)90113-7", "ISSN": ["0035-9203"], "issn-type": [{"value": "0035-9203", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:36:17Z", "timestamp": 1574336177038}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Pharmacokinetics"], "published-print": {"date-parts": [[1989, 7]]}, "DOI": "10.2165/00003088-198917010-00004", "type": "journal-article", "created": {"date-parts": [[2007, 12, 5]], "date-time": "2007-12-05T10:33:44Z", "timestamp": 1196850824000}, "page": "45-52", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Bayesian Forecasting of Serum Lithium Concentrations"], "prefix": "10.1007", "volume": "17", "author": [{"given": "Paul J.", "family": "Williams", "sequence": "first", "affiliation": []}, {"given": "Jerry L.", "family": "Browne", "sequence": "additional", "affiliation": []}, {"given": "Rajesh A.", "family": "Patel", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Clinical Pharmacokinetics"], "language": "en", "deposited": {"date-parts": [[2013, 1, 20]], "date-time": "2013-01-20T14:52:50Z", "timestamp": 1358693570000}, "score": 17.098854, "subtitle": ["Comparison with Traditional Methods"], "issued": {"date-parts": [[1989, 7]]}, "references-count": 0, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.2165/00003088-198917010-00004", "ISSN": ["0312-5963"], "issn-type": [{"value": "0312-5963", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T01:20:24Z", "timestamp": 1575163224248}, "reference-count": 0, "publisher": "The Haworth Press", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Employee Assistance Quarterly"], "published-print": {"date-parts": [[1988, 12, 19]]}, "DOI": "10.1300/j022v04v01_07", "type": "journal-article", "created": {"date-parts": [[2005, 7, 25]], "date-time": "2005-07-25T14:47:52Z", "timestamp": 1122302872000}, "page": "87-95", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The Chemical Family Affair:"], "prefix": "10.1300", "volume": "4", "author": [{"given": "Angela Christine", "family": "Browne", "sequence": "first", "affiliation": []}], "member": "260", "container-title": ["Employee Assistance Quarterly"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1300/J022v04v01_07", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T12:50:34Z", "timestamp": 1481633434000}, "score": 17.003754, "subtitle": ["Families and Drugs"], "issued": {"date-parts": [[1988, 12, 19]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1988, 12, 19]]}, "issue": "1"}, "alternative-id": ["10.1300/J022v04v01_07"], "URL": "http://dx.doi.org/10.1300/j022v04v01_07", "ISSN": ["0749-0003"], "issn-type": [{"value": "0749-0003", "type": "print"}], "subject": ["Medicine (miscellaneous)"]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T06:08:38Z", "timestamp": 1575094118968}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1632", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1854, 12, 1]], "date-time": "1854-12-01T00:00:00Z", "timestamp": -3631737600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet"], "published-print": {"date-parts": [[1854, 12]]}, "DOI": "10.1016/s0140-6736(02)54863-7", "type": "journal-article", "created": {"date-parts": [[2003, 9, 23]], "date-time": "2003-09-23T20:42:03Z", "timestamp": 1064349723000}, "page": "492-493", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ADULTERATION OF FOOD AND DRUGS."], "prefix": "10.1016", "volume": "64", "author": [{"given": "John", "family": "Postgate", "sequence": "first", "affiliation": []}, {"given": "AlfredHall", "family": "Browne", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Lancet"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0140673602548637?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0140673602548637?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 22]], "date-time": "2019-02-22T18:24:40Z", "timestamp": 1550859880000}, "score": 17.003754, "issued": {"date-parts": [[1854, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1854, 12]]}, "issue": "1632"}, "alternative-id": ["S0140673602548637"], "URL": "http://dx.doi.org/10.1016/s0140-6736(02)54863-7", "ISSN": ["0140-6736"], "issn-type": [{"value": "0140-6736", "type": "print"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T03:56:30Z", "timestamp": 1575258990823}, "reference-count": 36, "publisher": "Informa UK Limited", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Psychoactive Drugs"], "published-print": {"date-parts": [[2013, 7]]}, "DOI": "10.1080/02791072.2013.803648", "type": "journal-article", "created": {"date-parts": [[2013, 8, 2]], "date-time": "2013-08-02T15:11:52Z", "timestamp": 1375456312000}, "page": "258-265", "source": "Crossref", "is-referenced-by-count": 0, "title": ["John or Jane? Exploring How Clinical Judgment is Applied in Managing Access to Opioid Replacement Therapy"], "prefix": "10.1080", "volume": "45", "author": [{"given": "Warren", "family": "Harlow", "sequence": "first", "affiliation": []}, {"given": "Brenda", "family": "Happell", "sequence": "additional", "affiliation": []}, {"given": "Graeme", "family": "Browne", "sequence": "additional", "affiliation": []}], "member": "301", "reference": [{"key": "CIT0001", "author": "ACT Health", "year": "2010", "volume-title": "The ACT Opioid Maintenance Treatment Guidelines"}, {"key": "CIT0002", "DOI": "10.1111/j.1362-1017.2006.00162.x", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "author": "Australian Institute of Health and Welfare", "year": "2006", "volume-title": "National Health Labour Force Series"}, {"key": "CIT0004", "author": "Australian Institute of Health and Welfare", "year": "2009", "volume-title": "Alcohol & Other Drug Treatment Services in Australia 2007\u201308"}, {"key": "CIT0005", "author": "Australian Institute of Health and Welfare", "year": "2011", "volume-title": "Drug Statistics Series"}, {"key": "CIT0006", "author": "Australian Institute of Health and Welfare", "year": "2012", "volume-title": "National Opioid Pharmacotherapy Statistics Annual Data Collection: 2011 Report"}, {"key": "CIT0007", "DOI": "10.1016/j.drugalcdep.2005.05.010", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1111/j.1360-0443.1994.tb00927.x", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1016/S0740-5472(03)00038-2", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1111/j.1365-2702.2009.02988.x", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "author": "Brown L.", "year": "2007", "volume-title": "Guidelines for the Accreditation of Opioid Treatment Programs. Edited by Substance Abuse and Mental Health Services Administration"}, {"key": "CIT0012", "author": "Chalmers J.", "year": "2009", "volume-title": "Modelling Pharmacotherapy Maintenance in Australia: Exploring Affordability, Availability, Accessibility and Quality Using System Dynamics. Edited by Drug Policy Modelling Program University of New South Wales"}, {"key": "CIT0013", "author": "Charmaz K.", "year": "2006", "volume-title": "Constructing Grounded Theory: A Practical Guide through Qualitative Analysis"}, {"key": "CIT0014", "author": "Commonwealth of Australia", "year": "2008", "volume-title": "Alcohol & Other Drugs Treatment Services National Directory"}, {"key": "CIT0015", "author": "Cresswell J.", "volume-title": "Drug Addicts Turned Away from Stretched Methadone Clinic"}, {"key": "CIT0016", "author": "Dawe S.", "year": "2006", "volume-title": "Drug Use in the Family: Impacts and Implications for Children"}, {"key": "CIT0017", "author": "Drug and Alcohol Office", "year": "2007", "volume-title": "Western Australia: Clinical Policies and Procedures for the Use of Methadone and Buprenorphine in the Treatment of Opioid Dependence"}, {"key": "CIT0018", "author": "Drug and Alcohol Services South Australia, Flinders Medical Centre Pain Management Unit, and Royal Adelaide Hospital Pain Management Unit", "year": "2008", "volume-title": "Opioid Prescription in Chronic Pain Conditions: Guidelines for South Australian General Practitioners"}, {"key": "CIT0019", "author": "Drugs of Dependence Unit", "year": "2012", "volume-title": "DDU Information Circular: Interim Arrangement for Patients Pending Admission to QOTP"}, {"key": "CIT0020", "author": "Drugs of Dependence Unit Queensland", "year": "2008", "volume-title": "Queensland Opioid Treatment Program: Clinical Guidelines"}, {"key": "CIT0021", "author": "Duncan B.", "first-page": "20", "year": "2012", "journal-title": "Of Substance: The National Magazine on Alcohol, Tobacco and Other Drugs"}, {"key": "CIT0022", "DOI": "10.1016/S0740-5472(03)00040-0", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1046/j.1440-1614.2002.01088.x", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1111/j.1447-0349.2011.00748.x", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "author": "Intergovernmental Committee on Drugs", "year": "2007", "volume-title": "National Pharmacotherapy Policy: For People Dependant on Opioids"}, {"key": "CIT0026", "DOI": "10.1177/1359104506059122", "doi-asserted-by": "publisher"}, {"issue": "66", "key": "CIT0027", "first-page": "355", "volume": "19", "author": "La Rosa-Salas V.", "year": "2008", "journal-title": "Bioe'st"}, {"key": "CIT0028", "DOI": "10.1111/j.1525-1446.2008.00726.x", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "author": "Mental Health and Drug", "year": "2006", "volume-title": "Opioid Treatment Program: Clinical Guidelines for Methadone and Buprenorphine Treatment"}, {"issue": "8", "key": "CIT0030", "first-page": "61", "volume": "188", "author": "Mitchell G.K.", "year": "2008", "journal-title": "Medical Journal of Australia"}, {"key": "CIT0031", "author": "Oliver P.", "volume": "105", "first-page": "372", "year": "2009", "journal-title": "Addiction"}, {"key": "CIT0032", "DOI": "10.1111/j.1365-2648.2010.05275.x", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "author": "Riddle R.", "year": "2007", "volume-title": "The Cost of Drug-related Hospital Stays in Australia, 1999\u20132005"}, {"key": "CIT0034", "author": "Ritter A.", "year": "2009", "volume-title": "Drug Policy Modelling Program"}, {"key": "CIT0035", "author": "Shanahan M.", "year": "2007", "volume-title": "Estimating the Cost-savings of Reduced Crime While in Methadone Treatment"}, {"key": "CIT0036", "author": "Winstock A.", "year": "2008", "volume-title": "Survey of New South Wales Opioid Treatment Program Public Clinics: SWAT Report 3"}], "container-title": ["Journal of Psychoactive Drugs"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/02791072.2013.803648", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T09:51:18Z", "timestamp": 1481795478000}, "score": 16.617859, "issued": {"date-parts": [[2013, 7]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2013, 7]]}, "issue": "3"}, "alternative-id": ["10.1080/02791072.2013.803648"], "URL": "http://dx.doi.org/10.1080/02791072.2013.803648", "relation": {"cites": []}, "ISSN": ["0279-1072", "2159-9777"], "issn-type": [{"value": "0279-1072", "type": "print"}, {"value": "2159-9777", "type": "electronic"}], "subject": ["Medicine (miscellaneous)", "General Psychology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:04:19Z", "timestamp": 1574244259523}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Therapeutic Drug Monitoring"], "published-print": {"date-parts": [[1984, 3]]}, "DOI": "10.1097/00007691-198403000-00002", "type": "journal-article", "created": {"date-parts": [[2006, 11, 14]], "date-time": "2006-11-14T10:40:01Z", "timestamp": 1163500801000}, "page": "3-10", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Applications of Stable Isotope Methods to Studying the Clinical Pharmacology of Antiepileptic Drugs in Newborns, Infants, Children, and Adolescents"], "prefix": "10.1097", "volume": "6", "author": [{"given": "Thomas R.", "family": "Browne", "sequence": "first", "affiliation": []}, {"given": "Agnes Van", "family": "Langenhove", "sequence": "additional", "affiliation": []}, {"given": "Catherine E.", "family": "Costello", "sequence": "additional", "affiliation": []}, {"given": "Klaus", "family": "Biemann", "sequence": "additional", "affiliation": []}, {"given": "Gideon", "family": "Koren", "sequence": "additional", "affiliation": []}, {"given": "Natan", "family": "Brand", "sequence": "additional", "affiliation": []}, {"given": "Stuart M.", "family": "MacLeod", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Therapeutic Drug Monitoring"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T12:54:40Z", "timestamp": 1518180880000}, "score": 16.205385, "subtitle": [""], "issued": {"date-parts": [[1984, 3]]}, "references-count": 0, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1097/00007691-198403000-00002", "ISSN": ["0163-4356"], "issn-type": [{"value": "0163-4356", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:04:26Z", "timestamp": 1574154266411}, "reference-count": 32, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2003, 2, 6]], "date-time": "2003-02-06T00:00:00Z", "timestamp": 1044489600000}, "delay-in-days": 5, "content-version": "vor"}, {"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2003, 2, 1]], "date-time": "2003-02-01T00:00:00Z", "timestamp": 1044057600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Epilepsia"], "published-print": {"date-parts": [[2003, 2]]}, "DOI": "10.1046/j.1528-1157.2003.25302.x", "type": "journal-article", "created": {"date-parts": [[2003, 3, 11]], "date-time": "2003-03-11T20:05:29Z", "timestamp": 1047413129000}, "page": "171-178", "source": "Crossref", "is-referenced-by-count": 40, "title": ["Levetiracetam, a New Antiepileptic Agent: Lack of In Vitro and In Vivo Pharmacokinetic Interaction with Valproic\u2003Acid"], "prefix": "10.1111", "volume": "44", "author": [{"given": "Ren\u00e9", "family": "Coupez", "sequence": "first", "affiliation": [{"name": "UCB S.A. Pharma Sector, and the Brain Center, Brussels, Belgium; and"}]}, {"given": "Jean\u2010Marie", "family": "Nicolas", "sequence": "additional", "affiliation": [{"name": "UCB S.A. Pharma Sector, and the Brain Center, Brussels, Belgium; and"}]}, {"given": "Thomas\u2003R.", "family": "Browne", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, Boston University School of Medicine, Boston,\u2003Massachusetts,\u2003U.S.A."}]}], "member": "311", "published-online": {"date-parts": [[2003, 2, 6]]}, "reference": [{"key": "e_1_2_5_2_2", "DOI": "10.1016/S1059-1311(05)80184-0", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_3_2", "DOI": "10.2165/00003088-199631060-00005", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_4_2", "DOI": "10.1345/aph.17332", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_5_2", "DOI": "10.2165/00003088-199631030-00004", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_6_2", "DOI": "10.2165/00002018-199309030-00003", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_7_2", "DOI": "10.1097/00007691-197901000-00011", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_8_2", "DOI": "10.1136/jnnp.40.6.570", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_9_2", "DOI": "10.1038/clpt.1980.235", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_10_2", "DOI": "10.1002/j.1552-4604.1997.tb04301.x", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_11_2", "DOI": "10.1111/j.1365-2125.1990.tb03610.x", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_12_2", "DOI": "10.1111/j.1528-1157.1996.tb00518.x", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_13_2", "author": "Shorvon SD", "year": "2002", "article-title": "Levetiracetam, a pyrrolidone recently licensed as an antiepileptic drug.", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "e_1_2_5_14_2", "first-page": "250", "article-title": "In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent.", "volume": "27", "author": "Nicolas J\u2010M", "year": "1999", "journal-title": "Drug Metab Dispos"}, {"key": "e_1_2_5_15_2", "DOI": "10.1111/j.1528-1157.2000.tb00323.x", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_16_2", "DOI": "10.1111/j.1528-1157.2000.tb04605.x", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_17_2", "DOI": "10.1212/WNL.55.2.236", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_18_2", "DOI": "10.1016/0003-2697(85)90442-7", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_19_2", "DOI": "10.1093/bja/65.2.220", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_20_2", "DOI": "10.1111/j.1399-6576.1995.tb04035.x", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_21_2", "DOI": "10.1016/0006-2952(95)00071-7", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_22_2", "DOI": "10.1021/js9700558", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_23_2", "first-page": "1157", "article-title": "Bioactivation of the anticancer agent CPT\u201011 to SN\u201038 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions.", "volume": "25", "author": "Slatter J", "year": "1997", "journal-title": "Drug Metab Dispos"}, {"key": "e_1_2_5_24_2", "DOI": "10.2165/00003088-198510050-00002", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_25_2", "DOI": "10.1007/BF03189968", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_26_2", "author": "Center for Drug Evaluation and Research, Drug Information Branch", "year": "2000", "volume-title": "Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products:: general considerations"}, {"key": "e_1_2_5_27_2", "DOI": "10.2165/00044011-199510010-00007", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_28_2", "DOI": "10.1111/j.1528-1167.2001.00004.x", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_29_2", "DOI": "10.1016/S0163-7258(99)00052-2", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_30_2", "unstructured": "Nicolas J\u2010M Collart P Gerin B et al. Levetiracetam:in vitrometabolism assays and prediction of drug\u2010drug interaction. In: Boobis AR Kremers P Pelkonen O et al. eds.Cost B1: European cooperation in the field of scientific and technical research. European Symposium on Prediction of Drug Metabolism in Man: Progress and Problems.Li\u00e8ge Belgium 1998:193\u20135."}, {"key": "e_1_2_5_31_2", "DOI": "10.1023/A:1016264821127", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_32_2", "DOI": "10.1007/BF00544365", "doi-asserted-by": "publisher"}, {"key": "e_1_2_5_33_2", "first-page": "309", "article-title": "Probable pseudocholinesterase induction by valproic acid, carbamazepine and phenytoin leading to increased serum aspirin\u2010esterase activity in epileptics.", "volume": "9", "author": "Puche E", "year": "1989", "journal-title": "Int J Clin Pharmacol Res"}], "container-title": ["Epilepsia"], "language": "en", "link": [{"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1528-1157.2003.25302.x", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1046/j.1528-1157.2003.25302.x", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1528-1157.2003.25302.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 29]], "date-time": "2019-03-29T08:44:13Z", "timestamp": 1553849053000}, "score": 16.135485, "issued": {"date-parts": [[2003, 2]]}, "references-count": 32, "journal-issue": {"published-online": {"date-parts": [[2003, 2, 6]]}, "published-print": {"date-parts": [[2003, 2]]}, "issue": "2"}, "alternative-id": ["10.1046/j.1528-1157.2003.25302.x"], "URL": "http://dx.doi.org/10.1046/j.1528-1157.2003.25302.x", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0013-9580", "1528-1167"], "issn-type": [{"value": "0013-9580", "type": "print"}, {"value": "1528-1167", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}